SCHEMBL21140787

SCHEMBL21140787

CC(=O)OC1=CC2=CC[C@@H]3C(CC[C@]4(C)C(=O)CCC34)[C@H]2CC1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.69
CYP3A4 P08684 2/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CYP19A1 P11511 14/20 0.48
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
SHBG P04278 1/20 0.44
SERPINA6 P08185 1/20 0.44
GUSB P08236 1/20 0.44
G6PD P11413 1/20 0.44
PMP22 Q01453 1/20 0.44
KMT2A Q03164 1/20 0.44
GPBAR1 Q8TDU6 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2909333 1.00 SRD5A2 (0.69) SRD5A2CYP3A4CYP2C9CYP2C19TDP1
SCHEMBL9226234 0.89 SRD5A2 (0.68) SRD5A2CYP3A4ALDH1A1HSD17B10CYP19A1
SCHEMBL9226232 0.89 SRD5A2 (0.68) SRD5A2CYP3A4ALDH1A1HSD17B10CYP19A1
SCHEMBL17591557 0.84 SRD5A2 (0.63) SRD5A2CYP19A1
SCHEMBL17831186 0.84 SRD5A2 (0.63) SRD5A2CYP19A1
SCHEMBL15079264 0.84 SRD5A2 (0.63) SRD5A2CYP19A1
SCHEMBL6379452 0.84 SRD5A2 (0.63) SRD5A2CYP19A1
SCHEMBL11517545 0.82 SRD5A2 (0.73) SRD5A2CYP3A4CYP19A1MEN1LMNA
SCHEMBL13217277 0.82 SRD5A2 (0.47) SRD5A2ALDH1A1HSD17B10CYP19A1SHBG
SCHEMBL14199313 0.82 SRD5A2 (0.50) SRD5A2CYP3A4TDP1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3909966-A1 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY Sage Therapeutics, Inc. (US) 2021-11-17 EP disclosed
EP-3498725-B1 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY SAGE THERAPEUTICS INC (US) 2021-06-09 EP disclosed
EP-3498725-A1 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY Sage Therapeutics, Inc. (US) 2019-06-19 EP disclosed